Ongoing management of hepatitis C.
Harley
Hugh
H
Royal Adelaide Hospital, South Australia.
Shaw
David
D
Steven
Ian
I
D000998:Antiviral Agents / Q000627:therapeutic use*; D001315:Australia; D003131:Combined Modality Therapy; D000529:Complementary Therapies / Q000379:methods; D004032:Diet; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D005194:Family Practice / Q000379:methods; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification*; D018937:Hepatitis C Antibodies / Q000032:analysis; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000628:therapy* / Q000635:transmission; D006801:Humans; D008019:Life Style; D008134:Long-Term Care; D008297:Male; D010353:Patient Education as Topic / Q000379:methods; D016133:Polymerase Chain Reaction / Q000379:methods; D011379:Prognosis; D012367:RNA, Viral / Q000032:analysis; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate
D000998:Antiviral Agents; D018937:Hepatitis C Antibodies; D012367:RNA, Viral